Laura Mullaney1,2, Evelyn O'Shea2,3, Mary T Dunne2,4, Pierre G Thirion2,5, John G Armstrong2,5. 1. 1 Applied Radiation Therapy Trinity, Discipline of Radiation Therapy, Trinity College Dublin , Dublin , Ireland. 2. 2 Cancer Trials Ireland (formerly ICORG) , Dublin , Ireland. 3. 3 Coombe Women and Infants University Hospital , Dublin , Ireland. 4. 4 Clinical Trials Resource Unit, St. Luke's Hospital , Dublin , Ireland. 5. 5 Department of Radiation Oncology, Saint Luke's Radiation Oncology Network, St. Luke's Hospital , Dublin , Ireland.
Abstract
OBJECTIVE: : The aim of this study is to investigate if a handheld ultrasound device (BladderScan® BVI 6100) can accurately measure bladder volumes in prostate radiotherapy (RT) patients. METHODS: : A comparison was made of contoured bladder volumes based on treatment planning CT (TPCT) and BladderScan® BVI 6100 ultrasound device in a large prostate RT population. Three bladder volume (BV) measurements were taken using the bladder volume instrument (BVI) device on prostate RT patients immediately prior to TPCT (n = 190). The CT delineation bladder volumes were also recorded. The mean of the three BVI readings (BVImean) and the maximum (BVImax) of the readings were considered for a comparative analysis. RESULTS: : There was a strong positive correlation between the BVI and CT delineated bladder volumes (BVImean r = 0.825; BVImax r = 0.830). The mean difference [± standard deviation (SD)] was an underestimation of BV for both BVImean and BVImax (44.8 ± 88.2 ml and 32.9 ± 87.5 ml, respectively). CONCLUSION: : This is the largest study to date (n = 190), assessing the accuracy of the BladderScan® BVI 6100 in the prostate RT population. The BVI 6100 provides an acceptable indication of BV for use in prostate RT patients for the purposes of monitoring BV. ADVANCES IN KNOWLEDGE:: The BladderScan® BVI 6100 provides a convenient and non-irradiating method of indicating BV for use in prostate RT patients.
OBJECTIVE: : The aim of this study is to investigate if a handheld ultrasound device (BladderScan® BVI 6100) can accurately measure bladder volumes in prostate radiotherapy (RT) patients. METHODS: : A comparison was made of contoured bladder volumes based on treatment planning CT (TPCT) and BladderScan® BVI 6100 ultrasound device in a large prostate RT population. Three bladder volume (BV) measurements were taken using the bladder volume instrument (BVI) device on prostate RT patients immediately prior to TPCT (n = 190). The CT delineation bladder volumes were also recorded. The mean of the three BVI readings (BVImean) and the maximum (BVImax) of the readings were considered for a comparative analysis. RESULTS: : There was a strong positive correlation between the BVI and CT delineated bladder volumes (BVImean r = 0.825; BVImax r = 0.830). The mean difference [± standard deviation (SD)] was an underestimation of BV for both BVImean and BVImax (44.8 ± 88.2 ml and 32.9 ± 87.5 ml, respectively). CONCLUSION: : This is the largest study to date (n = 190), assessing the accuracy of the BladderScan® BVI 6100 in the prostate RT population. The BVI 6100 provides an acceptable indication of BV for use in prostate RT patients for the purposes of monitoring BV. ADVANCES IN KNOWLEDGE:: The BladderScan® BVI 6100 provides a convenient and non-irradiating method of indicating BV for use in prostate RT patients.
Authors: A V D'Amico; J Manola; M Loffredo; L Lopes; K Nissen; D A O'Farrell; L Gordon; C M Tempany; R A Cormack Journal: Int J Radiat Oncol Biol Phys Date: 2001-12-01 Impact factor: 7.038
Authors: S Hynds; C K McGarry; D M Mitchell; S Early; L Shum; D P Stewart; J A Harney; C R Cardwell; J M O'Sullivan Journal: Br J Radiol Date: 2010-12-15 Impact factor: 3.039
Authors: Marcel R Stam; Emile N J Th van Lin; Lisette P van der Vight; Johannes H A M Kaanders; Andries G Visser Journal: Int J Radiat Oncol Biol Phys Date: 2006-03-15 Impact factor: 7.038
Authors: Rozilawati Ahmad; Mischa S Hoogeman; Sandra Quint; Jan Willem Mens; Ilse de Pree; Ben J M Heijmen Journal: Radiother Oncol Date: 2008-08-12 Impact factor: 6.280
Authors: Laura M Mullaney; Evelyn O'Shea; Mary T Dunne; Marie A Finn; Pierre G Thirion; Lesley Ann Cleary; Maeve McGarry; Louise O'Neill; John G Armstrong Journal: Pract Radiat Oncol Date: 2014-01-08
Authors: Una M O'Doherty; Helen A McNair; Andrew R Norman; Elizabeth Miles; Simon Hooper; Mark Davies; Naomi Lincoln; Jan Balyckyi; Peter Childs; David P Dearnaley; Robert A Huddart Journal: Radiother Oncol Date: 2006-06-16 Impact factor: 6.280